A Focus On Small Molecules In Myeloma

A Focus on Small Molecules in Myeloma

International Academy for Clinical Hematology IACH

Dr. Rodriguez on Evolving Role of Small Molecules in Multiple Myeloma

Novel small molecules in multiple myeloma: Update on key results from emerging clinical studies

Emerging Small Molecule Therapies with Promise in Myeloma

Novel Small Molecule Inhibitors in Multiple Myeloma

New paradigms/therapies in relapsed/refractory myeloma: Small molecules & monoclonal antibodies

The Potential Utility of CLR 131 in Multiple Myeloma

Myeloma Crowd Radio: Using Nanotechnology in Multiple Myeloma

HealthTree Foundation for Multiple Myeloma

Myc and Multiple Myeloma: Drugging the Undruggable

James Bradner: "Small molecule therapeutics" (11/24/2020)

MIT Department of Biology

Cereblon pathway-mediated IMiD resistance in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr Lev Kats: Improving treatment outcomes for multiple myeloma

Leukaemia Foundation - Blood Cancer Information

The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors

ASH Annual Meeting: Focus on New Multiple Myeloma Data

Novel immunotherapy and small molecule inhibitor combinations

Mapping Long Noncoding RNA Dependencies in Tumor Cells; by Eugenio Morelli M.D.

IMF Patient & Family Webinar - New Frontiers In Myeloma Care

International Myeloma Foundation

The Future of Myeloma Drug Development | Dickran Kazandjian, MD

HealthTree Foundation for Multiple Myeloma

Probing the Myeloma Immune MicroEnvironment One Cell at A Time (Single-Cell Sequencing)

HealthTree Foundation for Multiple Myeloma

Dr. Richardson on Treatment Approaches Targeting Mutational Burden in Myeloma